-
NewAmsterdam Pharma (NASDAQ:NAMS) Given Average Recommendation of "Buy" by Brokerages
Source: Buzz FX / 06 Nov 2024 05:07:16 America/New_York
NewAmsterdam Pharma (NASDAQ:NAMS) Given Average Recommendation of "Buy" by Brokerages Written by MarketBeat November 6, 2024 Share Link copied to clipboard. NewAmsterdam Pharma ( NASDAQ:NAMS - Get Free Report ) has earned a consensus recomm
Read more...